Namrata Vijayvergia

发表

Review and Updates on Approaches to Neoadjuvant Chemotherapy in Rectal Cancer

Thomas L Holden, Namrata Vijayvergia, 2021, Current Colorectal Cancer Reports.

BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations

Roland L. Dunbrack, W. El-Deiry, J. Swensen, 2017, Oncotarget.

First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer.

K. White, W. El-Deiry, H. Cooper, 2020, Clinical colorectal cancer.

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study

P. Engstrom, H. Cooper, I. Astsaturov, 2016, British Journal of Cancer.

Targeted Therapies in the Management of Well-Differentiated Digestive and Lung Neuroendocrine Neoplasms

A. Dasari, Namrata Vijayvergia, 2020, Current Treatment Options in Oncology.

Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms

P. Engstrom, E. Dulaimi, R. Alpaugh, 2021, Cancer Immunology, Immunotherapy.

Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal Cancer.

William H. Ward, M. Einarson, I. Astsaturov, 2021, JCO clinical cancer informatics.

Incidence of asymptomatic COVID-19 positivity in cancer patients and effects on therapy

D. Baldwin, E. Handorf, Namrata Vijayvergia, 2021, Journal of Cancer Research and Clinical Oncology.

Chemotherapy Use and Survival in Older Metastatic Pancreatic Cancer Patients in the Combination Therapy Era

K. Devarajan, S. Crystal, Steven J. Cohen, 2020 .

NRG-GI002: A phase II clinical trial platform for total neoadjuvant therapy (TNT) in rectal cancer.

N. Wolmark, K. Pogue-Geile, G. Yothers, 2017 .

A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors

G. Pelosi, M. Papotti, A. Albini, 2021, Endocrine Pathology.

Therapeutic biomarker differences between MSI-H and MSS colorectal cancers.

W. El-Deiry, H. Lynch, Z. Gatalica, 2015 .

Classification of pulmonary neuroendocrine tumors: new insights.

G. Pelosi, M. Papotti, A. Albini, 2017, Translational lung cancer research.

Exploring Real World Outcomes with Nivolumab Plus Ipilimumab in Patients with Metastatic Extra-Pulmonary Neuroendocrine Carcinoma (EP-NEC)

P. Fu, Lisa Liu, Namrata Vijayvergia, 2022, Cancers.

Cytotoxic Therapy in Advanced Pancreatic Cancer: Where We Are and Where We Are Headed

Namrata Vijayvergia, S. Cohen, 2018 .

Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer

R. Mehra, Namrata Vijayvergia, 2014, Cancer Chemotherapy and Pharmacology.

Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy era.

K. Devarajan, C. Denlinger, R. Jain, 2020, Journal of geriatric oncology.

Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients.

Shannon M. Lynch, E. Dotan, E. Handorf, 2019, Journal of gastrointestinal oncology.

Personalized medicine in sporadic pancreatic cancer without homologous recombination-deficiency: are we any closer?

Namrata Vijayvergia, S. Cohen, 2016, Journal of gastrointestinal oncology.

Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience.

Julianna C. Ricco, K. Devarajan, Sameer Gupta, 2015, Journal of geriatric oncology.

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

T. Giordano, A. Benson, M. Soulen, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials

P. Engstrom, S. Litwin, M. Hall, 2020, British Journal of Cancer.

Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward.

C. Denlinger, Namrata Vijayvergia, Prashant C Shah, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites

W. El-Deiry, Z. Gatalica, B. Lim, 2015, Cancer biology & therapy.

Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Initial Results From the Pembrolizumab Arm of a Phase 2 Randomized Clinical Trial.

N. Wolmark, R. Valicenti, G. Yothers, 2021, JAMA oncology.

Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed

C. Denlinger, Namrata Vijayvergia, 2015, Journal of personalized medicine.

Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer

M. Hall, Y. Wong, Tianyu Li, 2016, Cancer.

NSABP B-59/GBG 96-GeparDouze: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy (NAC) with atezolizumab or placebo in Patients (pts) with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo.

C. Denkert, J. Costantino, C. Geyer, 2018 .

Long-term results from NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC).

G. Yothers, T. George, L. Kachnic, 2023, Journal of Clinical Oncology.

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—First experimental arm (EA) initial results.

N. Wolmark, G. Yothers, T. George, 2019, Journal of Clinical Oncology.

NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—Pembrolizumab experimental arm (EA) primary results.

N. Wolmark, G. Yothers, T. George, 2021 .

Venous thromboembolism in metastatic pancreatic cancer

Shannon M. Lynch, E. Dotan, R. Pandey, 2023, European journal of haematology.

Real world usage of gemcitabine and nabpaclitaxel in older adults with metastatic pancreatic cancer: A single institution experience.

E. Dotan, E. Handorf, Namrata Vijayvergia, 2019, Journal of Clinical Oncology.

Reduced PD-1/PD-L1 expression in KRAS-mutant versus wild-type microsatellite instable (MSI-H) colorectal cancer (CRC) and association of wnt pathway corepressor TLE-3.

W. El-Deiry, Z. Gatalica, S. Grivennikov, 2015 .

NRG-GI002: A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer.

N. Wolmark, K. Pogue-Geile, G. Yothers, 2018 .